Biochemical Reagent
-
BA6324 NCI126224Summary: NCI126224 is a signaling inhibitor. -
BA6325 BNT411Summary: BNT411 is a selective agonist that induces IFNa release in vivo and in vitro.
-
BA6326 CU-CPD107Summary: CU-CPD107 is a potent selective agonist.
-
BA6327 MobocertinibSummary: Mobocertinib (TAK-788) is an orally effective and irreversible inhibitor. -
BA6328 PyrotinibSummary: Pyrotinib (SHR-1258) is a potent and selective dual inhibitor.
-
BA6329 BLU-945Summary: BLU-945 is a potent, highly selective, reversible epidermal growth factor receptor tyrosine kinase inhibitor (TKIs) with oral activity.
-
BA6330 LazertinibSummary: A potent, reversible, orally available, blood-brain barrier-crossing, mutant-selective, third-generation tyrosine kinase inhibitor. -
BA6331 SunvozertinibSummary: Sunvozertinib (DZD9008) is a potent (EGFR, Her2, especially mutant) inhibitor. -
BA6332 TX1-85-1Summary: TX1-85-1 is an irreversible inhibitor.
-
BA6333 BI-4020Summary: BI-4020 is a fourth generation, orally active, non-covalent tyrosine kinase inhibitor.